// App-Quantinova.ai

TCT CONNECT-66 : Ischemic and Bleeding Outcomes in Patients With Versus Without Atrial Fibrillation: Analysis From the Onyx ONE Month DAPT Program

Researchers

Presenter

  • Sanjeevan Pasupati

Principal Investigators

  • Azeem Latib

  • Elvin Kedhi

  • Ajay Kirtane

  • David Kandzari

  • Roxana Mehran

  • Matthew Price

  • Daniel Simon

  • Alexandre Abizaid

  • Stephen G. Worthley

  • Azfar Zaman

  • Maria Parke

  • Te-Hsin Lung

  • Stephan Windecker

  • Gregg Stone

Medical Centers

  • Waikato Hospital, Hamilton, New Zealand

  • Medtronic, San Jose, California, USA

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Medtronic, Forest Lake, Minnesota, USA

  • Scripps Clinic, La Jolla, California

  • University Hospitals Case Medical Center, Cleveland, OH

  • Diagram, Zwolle, the Netherlands

  • NewYork–Presbyterian/Columbia University Irving Medical Center, New York, New York, USA

  • Montefiore Medical Center, New York, NY

  • Instituto Dante Pazzanese of Cardiology, Sao Paulo, Sao Paulo, Brazil

  • Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine, New York, New York

  • Piedmont Heart Institute, Atlanta, GA

  • Swiss Cardiovascular Center Bern, Bern, Switzerland

  • Mount Sinai Heart Health System, New York, New York, USA

  • Genesis Healthcare, Sydney, Victoria, Australia

Locations

  • New Zealand

  • United States

  • Brazil

  • United Kingdom

  • Georgia

  • Switzerland

  • Netherlands

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved